Fundraising FoxBold Capital Partners — 2025 Investments
12 investments dated 2025 · listed companies and verified rows first · show all
Celularity is a regenerative and cellular medicine company developing and commercializing biomaterial products and allogeneic, cryopreserved cell therapies derived from the postpartum placenta to target age-related diseases.
BiotechHealthtechLongevityFlorham Park, US
Robert J. Hariri(Executive Officer, Director)inJoseph DosSantos(Chief Financial Officer)inJohn R. Haines(Executive Officer)inStephen A. Brigido(President, Degenerative Disease)inBradley Glover(Executive Officer)Andrew L. Pecora(Executive Officer)in
Board seatPeter H. Diamandis· per SEC Form D · $6.7M raise · filed Nov 2025
Co-investorsAlumni VenturesBlue Ivy VenturesCastor VenturesPHD Ventures
American Bitcoin operates a Bitcoin mining platform focused on low-cost, large-scale Bitcoin production and accumulation to maximize Bitcoin-per-share.
Crypto & Web3FintechMiami, US
Michael Ho(Executive Officer, Director)Matt Prusak(President and Interim Chief Financial Officer)in
BoardJustin Mateen(Director)Asher Genoot(Director)inMichael Broukhim(Director)in
Co-investorsWinklevoss Capital
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOrange County, US
Alaina Brinley Rajagopal(Founder)inAditya Rajagopal(Co-founder & CEO)inYaser Abu-Mostafa(Co-founder)Lynne Rollins(Chief Financial Officer)Raymond Jimenez(Chief Technology Officer)inJeff Stoll(Chief Product Officer)in
Co-investorsCatalyst Health VenturesFREEFLOWMaverick VenturesWavemaker Three-Sixty Health
Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.
BiotechHealthtechMedical DevicesSan Diego, US
Aaron Hirschhorn(Founder)Linda Black(Chief Executive Officer; founding team member)inDavis Brimer(Executive Officer, Director)Beau Becker(Head of Strategic Operations & People Effectiveness; founding team member)in
BoardValentine Williams(DVM, MS, Diplomate ACVS)
Board seatTeymour Boutros-Ghali· per SEC Form D
Co-investorsAlpha EdisonAlumni VenturesBaroda VenturesBling CapitalExpansion Venture CapitalMaveron+3 more
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia.
BiotechHealthtechWellness & FitnessWaltham, US
ILISSA LARIMORE(Executive Officer)inGERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)
BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)in
Board seatNeal Bhadkamkar· per SEC Form D
Co-investorsJoyance PartnersOlive Tree CapitalRising TideDigitalDx VenturesGISEV Family OfficeS2G Investments+2 more
BORNTOSTANDOUT produces high-concentration eau de parfum fragrances for consumers seeking niche, unconventional perfumes with distinctive longevity and presence.
ConsumerDirect to Consumer
Co-investorsTouch Capital
Chef provides a platform for automating infrastructure operations and DevOps workflows across cloud, on-premises, and hybrid environments.
Cloud ComputingDeveloper ToolsEnterprise Software
Adam Jacob(Founder)inBarry Steinglass(Founder)Jesse Robbins(Founder)Joshua Timberman(Founder)Nathan Haneysmith(Founder)Nathen Haneysmith(Founder)
Co-investorsAmplify PartnersAvataar Venture PartnersBattery VenturesHCVCMillennium Technology Value PartnersThreshold Ventures+9 more
Chef Robotics builds AI-powered robots for automated meal assembly and food preparation, designed to handle the natural variability of food ingredients and high-mix production.
AI & Machine LearningFoodTechRobotics
Rajat Bhageria(Founder)in
Co-investorsAlumni VenturesAvataar Venture PartnersBasecamp FundBloomberg BetaConstruct CapitalCross Culture Ventures+18 more
Fountain Life is a private preventive health membership service that uses AI-guided diagnostics, physician-led interpretation, and restorative therapeutics to detect issues early and create personalized plans focused on healthspan and longevity.
AI & Machine LearningDigital HealthHealthtechLongevityOrlando, US
Anthony Robbins(Director)Robert Hariri, MD(Founding Partner)Peter H. Diamandis, MD(Co-Founder / Founding Partner)inWilliam K. Kapp, III, MD(Director)Dr. William Kapp(Co-Founder & CEO)Tony Robbins(Founding Partner)
Co-investorsBOLD LongevityEos Venture Partners LimitedPHD VenturesSeed Healthcare
Gist provides brand visibility and advertising solutions for the generative AI marketplace, offering custom AI search, engagement tools, and data-powered insights to help brands and marketers maintain visibility and performance in AI-driven digital environments.
AdTechAI & Machine LearningMarketing TechPasadena, US
Bill Gross(CEO of ProRata & Gist)
Co-investorsFelicis VenturesMayfield FundBettor CapitalCalibrate VenturesJDS SportsMVP Ventures+2 more
Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations.
Digital HealthHealthtechMedical DevicesSaaSBaltimore, US
Sebastian Seiguer(Entrepreneur & Founder)inMorad ElmiSebastian Seiguer, JD, MBA(Founder)inMorad E.(Founder)in
Co-investorsGaingelsKapor CapitalTCP Venture CapitalABS Capital PartnersGreycroftPTX Capital+1 more
__Twitter.png)
Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.
BiotechDeep TechDigital HealthHealthtechBoston, US
Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)
BoardTeymour Boutros-Ghali(Director)inMartin Madaus(Director)
Co-investorsBill & Melinda Gates FoundationCerity Partners VenturesColorcon VenturesPortal InnovationsSafar PartnersSky9 Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.